Home » Stocks » SDGR

Schrodinger, Inc. (SDGR)

Stock Price: $69.88 USD -0.20 (-0.29%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Pre-market: $69.00 -0.88 (-1.26%) Jul 26, 9:01 AM
Market Cap 4.93B
Revenue (ttm) 114.05M
Net Income (ttm) -10.67M
Shares Out 61.34M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $69.88
Previous Close $70.08
Change ($) -0.20
Change (%) -0.29%
Day's Open 70.11
Day's Range 68.03 - 70.56
Day's Volume 244,919
52-Week Range 46.27 - 117.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).

1 week ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in July.

1 week ago - Business Wire

I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that.

Other stocks mentioned: OPRX, ROKU, SE, SHOP, SI, SQ
3 weeks ago - The Motley Fool

I'm an owner of Schrodinger because this company's software is revolutionizing drug discovery, and it's going to be a monster stock over the next decade.

Other stocks mentioned: VEEV
4 weeks ago - The Motley Fool

NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).

1 month ago - Business Wire

Searching for stocks to buy that could legitimately double before 2022? These seven are in position to do just that.

Other stocks mentioned: CROX, NIO, OCGN, RBLX, TDOC, XPEV
1 month ago - InvestorPlace

These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential ap...

Other stocks mentioned: BNGO, ILMN, MRNA, NVTA
1 month ago - InvestorPlace

NEW YORK--(BUSINESS WIRE)--Ajax Therapeutics Raises $40 Million Financing To Develop Novel Small Molecules Targeting Cytokine Signaling Pathways for Hematologic Malignancies

1 month ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will present at two investor conferences in June.

2 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today reported Inducement Grants under Nasdaq Listing Rule 5635(c)(4).

2 months ago - Business Wire

Here are seven biotech stocks with loads of innovation and plenty of catalysts to make money for smart investors. The post 7 Best Biotech Stocks To Buy in 2021 as Innovation Takes Center Stage appeared ...

Other stocks mentioned: CERC, CRSP, HZNP, JNJ, LLY, TAK
2 months ago - InvestorPlace

Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of 100.00% and 10.02%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Schrodinger (NASDAQ:SDGR) decreased 1.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 100.00% over the past year to $0.00, which ...

2 months ago - Benzinga

NEW YORK--(BUSINESS WIRE)---- $SDGR #earnings--Schrödinger reported financial results for the first quarter of 2021 and provided a company update.

2 months ago - Business Wire

Schrodinger's (SDGR) first-quarter results are likely to reflect benefits from collaborations.

2 months ago - Zacks Investment Research

Schrodinger, Inc. (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will participate in the Bank of America Securities 2021 Virtual Healthcare Conference.

2 months ago - Business Wire

vTv Therapeutics, Arrival, PubMatic, and Schrodinger are four up-and-coming stocks to buy. All four are benefiting from rapidly shifting trends.

Other stocks mentioned: ARVL, PUBM, VTVT
2 months ago - InvestorPlace

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will report first quarter 2021 financial results on May 11, 2021.

2 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger announced grants made to newly-hired employees pursuant to the company's 2021 Inducement Equity Incentive Plan.

3 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger presented new preclinical data from its CDC7 inhibitor program during AACR 21 Annual Virtual Meeting.

3 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that the company will participate in the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery.

3 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger will host a webcast to review the preclinical data being presented at the AACR Annual Meeting.

3 months ago - Business Wire

These three companies have just one thing in common: the potential to offer a long-term windfall for stockholders.

Other stocks mentioned: OPEN, SKLZ
3 months ago - The Motley Fool

Wood's biotech fund owns almost $200 million worth of Schrodinger, about 2% of the company. Here's why she's an investor.

4 months ago - The Motley Fool

NEW YORK--(BUSINESS WIRE)--Schrödinger will participate in the virtual Credit Suisse 2021 Healthcare Innovators Series on March 23, 2021.

4 months ago - Business Wire

This drug discovery company's stock just took a major hit.

4 months ago - The Motley Fool

NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger announced that preclinical data from its CDC7 program will be presented at the AACR Annual Meeting.

4 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)---- $SDGR #earnings--Schrödinger today reported financial results for the fourth quarter and full year 2020.

4 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview during the H.C. Wainwright Global Life Sciences Conference.

4 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it has expanded its collaboration with Google Cloud.

5 months ago - Business Wire

Schrodinger is an exciting, next generation drug development and software player. However, at its core, it is a molecular modelling company, leading to vast opportunities. The TAM of the markets in whic...

6 months ago - Seeking Alpha

The biotechnology exchange-traded fund SPDR S&P Biotech ETF (NYSE: XBI) is up around 50% in 2020 and Jefferies' managing director Michael Yee says the valuations are not only justified but sustainable i...

Other stocks mentioned: MORF, OLMA
6 months ago - Invezz

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, presented preclinical data from its ...

7 months ago - Business Wire

The company announced a partnership with Bristol Myers Squibb.

8 months ago - The Motley Fool

Schrödinger Inc. shares jumped about 8% in premarket trade Monday, after the company announced a drug discovery agreement with Bristol Myers Squibb Co. that could net it up to $2.7 billion in milestone ...

Other stocks mentioned: BMY
8 months ago - Market Watch

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery collabor...

Other stocks mentioned: BMY
8 months ago - Business Wire

Schrödinger stock is almost at half the price since peaking in the summer. Stock dilution hurt investors, but the market is betting on its software growth.

8 months ago - Seeking Alpha

Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results fo...

8 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that members of the ...

8 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced it will present data...

8 months ago - Business Wire

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced it will host a conference ...

8 months ago - Business Wire

Big Tech companies have been the hottest stocks on Wall Street all year, pre- and post-pandemic. But some experts think it's time for a new crop of dynamic up-and-comers in fields like virtual reality a...

Other stocks mentioned: CRWD, DDOG, GH, OKTA, U, ZS
9 months ago - CNN Business

Schrodinger (SDGR) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

Schrödinger, Inc. has exhibited a stock price slide since July, even as revenue growth continues above expectations.

10 months ago - Seeking Alpha

Three great performing yet relatively unknown med-tech stocks with a high upside.

Other stocks mentioned: SLP, VEEV
10 months ago - The Motley Fool

Schrödinger's computational platform integrates physics-based methods with machine-learning techniques to enable drug discovery and development of novel materials.

11 months ago - Seeking Alpha

Schrödinger has an innovative computational platform that accelerates the discovery of new molecules for use in therapeutics and industrial materials.

11 months ago - Seeking Alpha

Schrodinger (SDGR) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

11 months ago - Zacks Investment Research

About SDGR

Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharma... [Read more...]

Industry
Health Information Services
IPO Date
Feb 6, 2020
Stock Exchange
NASDAQ
Ticker Symbol
SDGR
Full Company Profile

Financial Performance

In 2020, Schrodinger's revenue was $108.10 million, an increase of 26.36% compared to the previous year's $85.54 million. Losses were -$24.46 million, -0.44% less than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Schrodinger stock is "Buy." The 12-month stock price forecast is 89.60, which is an increase of 28.22% from the latest price.

Price Target
$89.60
(28.22% upside)
Analyst Consensus: Buy